BackAddex Therapeutics Overview

Addex Therapeutics Research & Development

Research & Development expenses for ADXN.

Quarterly R&D Expenses

$52753.00
↓ 946.89% YoY

As of Dec 31, 2025

Annual R&D Expenses (TTM)

$405046.00
↓ 19.19% YoY

Trailing 12 months ending Dec 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin